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determined by correlating the recipient's serum reactivity 
against the T and B lymphocyte and monocyte populations as 
well as the use of HLA-specific monoclonal blocking antibodies. 
Thus, a procedure is now available for better prediction of graft 
survival in the recipient. The usefulness of this new procedure 
is particularly important in patients with high levels of sensi-
tization. Investigators have noted that finding a serologically 
compatible kidney for these individuals is very difficult (I5). 
Since the modified flow cytometric procedure can make the 
distinction between deleterious and irrelevant antibodies, some 
potential recipients may still be considered for transplantation 
with an available kidney despite a positive B cell crossmatch 
result. In conjunction with the CDC assay, we intend to use 
this modified flow cytometric cross match technique to study 
antibodies reactive with donor leukocytes in order to improve 
the success rate of renal transplantation. 
In summary, we have described a modified flow cytometric 
crossmatch technique that utilizes donor peripheral blood leu-
kocytes. The use of leukocytes provides a wider spectrum of 
antigens and has the potential to distinguish between antibod-
ies that are detrimental and those that have no effect on graft 
survival. The procedure can also be performed in a shorter 
period of time than lymphocytotoxicity and previous flow cy-
tometry crossmatch procedures. Three cases were described in 
which the modified crossmatch procedure was useful in char-
acterizing the antibody responsible for the positive B cell CDC 
crossmatch. The application of this procedure in renal trans-
plantation allows for the use of extended phases of crossmatch 
testing, thus enhancing the probability of graft survival. At the 
same time, some potential allograft recipients are not excluded 
from consideration for transplantation solely on the basis of a 
positive crossmatch result. 
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LATE COMPLICATIONS WITH GALLBLADDER CONDUIT BILIARY RECONSTRUCTION AFTER LIVER 
TRANSPLANTATION! 
The preferred techniques for biliary tract reconstruction with 
liver transplantation are duct-to-duct anastomosis over a T-
tube stent or anastomosis of the graft common duct to a 
defunctionalized Roux limb of jejunum (1-3). A more complex 
but occasionally useful procedure is the gallbladder conduit 
operation, which was recommended by Waddell and Grover (4) 
for use in liver transplantation and adapted by CaIne (5) for 
this purpose. 
In our own experience with almost 2000 liver transplanta-
tions, the Waddell-Calne option for biliary reconstruction has 
'This work was supported by Research Grants from the Veterans 
Administration and by Project Grant DK29961 from the National 
Institutes of Health, Bethesda, MD. 
been exercised on only 10 occasions. In most ofthe 10 patients 
(Table 1), multiple previous operations had caused extensive 
scarring, and/or there had been the loss of a large portion of 
the small bowel, either from construction of multiple Roux 
limbs or because of extensive intestinal resections for other 
reasons. The use of the gallbladder conduit under these circum-
stances either obviated the need for extensive dissections, per-
mitted the use of a short residual Roux limb, or allowed both 
advantages. 
The biliary reconstructions were performed exactly as de-
scribed by Caine (5). In essence, the donor common duct is 
anastomosed to the base of the donor gallbladder (Hartman's 
pounch) and the fundus of the gallbladder is anastomosed to 
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TABLE 1. Complications of gallbladder conduit biliary reconstruction 
Age at Date of Multiple 01" No. transplantation transplantation previous 
operations 
235 45 8/8/82 Yes 
250 3 8/22/82 Yes 
768b 22 10/5/88 Yes 
1277 2 10/28/87 Yes 
1305 44 10/20/87 No 
1321 20 12/8/87 Yes 
1371 Ph 1/17/88 Yes 
1402 3 2/13/88 Yes 
1601 54 7/6/88 Yes 
1732 53 10/11/88 Yes 
·OT, orthotopic transplantation. 
b Retransplantation-first transplantation was 4/21/86. 
FIGURE 1. Biliary reconstruction with a gallbladder conduit. The 
T-tuhe pasaetl through the proximal and distal anastomosis and out 
through the gallbladder wall to the skin. 
the recipient bowel or to the recipient common bile duct. The 
proximal limb of aT-tube is passed through the choledocho-
cholecystostomy anastomosis and the distal T-Iimb is passed 
through the anastomosis of the gallbladder fundus to the intes-
Time to Complication 
revision Status 
No complication No revision Alive and well 
Gallstone/chol- 5 Years Alive and well 
angitis 
No complication No revision Died 3 weeks 
pOStoP· 
Gallstone/chol- 1 Years Alive and well 
angitis 
No complication No revision Alive and well 
No complication No revision Alive and well 
No complication No revision Alive and well 
Siudge/cholan- 6 Months Alive and well 
gitis 
Increased liver 3.5 Months Alive and well 
enzymes/ gall-
stone 
No complication No revision Died 9 weeks 
pOStoP. 
FIGURE 2. Transhepatic cholangiogram 5 years after transplanta-
tion and biliary reconstruction with gallbladder conduit. 
tine or recipient common duct. The T-limb of the T-tube is 
brought through the gallbladder wall to the skin (Fig. 1). 
Eight of the 10 patients survived chronically after operation 
and have been followed for 6 months to 6- lh years. The other 
two died after 3 and 4 weeks. The bile duct reconstruction was 
not a factor in their deaths. Of the 8 who are alive. 4 developed 
biliary tract stones, sludge, or strictures, and usually all 3 (Table 
1 ). 
A typical late complication is shown in Figure 2. The stricture 
occurred at the site of the anastomosis between the donor duct 
and the gallbladder. The stones were found in the donor duct, 
the gallbladder. or both places (Fig. 2). Reoperation was re-
quired in each instance with conversion to a choledochojeju-
nostomy 0.3, I, 3.5, and 5 years after the transplantation. The 
symptoms leading to operation were life-threatening in 3 pa-
tients with severe cholangitis. The fourth patient had silent 
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By 1974. the devastating effect of biliary tract complications 
after liver transplantation had been recognized and the need 
for improved techniques was obvious (6). The options settled 
upon in our program were either choledochojejunostomy or 
choledochocholedochostomy with aT-tube stent (1-3). The 
alternative technique of reconstruction with a donor gallbladder 
conduit has the advantages of providing a double passage of 
bile from the new liver via the common duct and cystic duct. 
as well as easy access for postoperative irrigation through a 
carefully placed T -tube. In addition. dangerous dissections and 
loss of additional jejunal length can be avoided in patients with 
multiple previous operations. With this method. the rate of 
complications in the Cambridge program was substantially 
reduced (7). 
However. it has not been appreciated that sludge and stone 
formation would be a common late complication. particularly 
in pediatric recipients. In our small series of only 10 patients, 
reoperation became necessary as early as 3.5 months after 
transplantation, and as late as 5 years. The potential hazards 
as well as the inconvenience inherent in this method of biliary 
tract reconstruction should preclude its use except for those 
specific indications already mentioned. 
In summary, the Waddell-Caine method of biliary tract re-
construction using a gallbladder conduit was associated with a 
50% incidence of late biliary tract'sludge or stone formation, 
with obstruction and frequent cholangitis. This procedure 
should not be used for the biliary tract reconstruction of liver 
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NONTROPICAL PYOMYOSITIS IN A RENAL ALLOGRAIT RECIPIENT 
Pyomyositis (pyomyositis tropicans) is an abscess-forming 
bacterial infection of skeletal muscle. This illness usually occurs 
in tropical climates. where it is well recognized, but is infre-
quently diagnosed in nontropical climates. It is, however, being 
recognized with increasing frequency in the United States. 
Although trauma, parasitic and viral infections, nutritional and 
other metabolic factors have been implicated, the exact patho-
physiologic mechanisms leading to bacterial infection of skel-
etal muscle are unknown. Staphyiococcu.s aureu.s is almost 
always the offending organism but the disease can be caused 
by virulent streptococci and other species. The disease occurs 
most often in males and in younger patients. Pyomyositis 
carries an important morbidity and mortality if not diagnosed 
properly and treated aggressively with antibiotics, as well as 
surgical intervention (1-8). 
We present the first published case of nontropical pyomyo-
sitis occurring in a renal allograft recipient and comment on 
the presenting features, diagnosis, and therapy of the disease 
in this paper. 
The patient is a 53-year-old white male with end-stage renal 
disease secondary to chronic glomerulonephritis. He underwent 
a cadaver donor renal transplant in 1978 which was lost to 
chronic rejection in 1985'. He returned to dialysis at that time 
and underwent a second cadaver donor renal transplant in 
December 1987. Since that time he has enjoyed excellent allo-
graft function (baseline serum creatinine 1.4-1.7 mg/dl). His 
maintenance immunosuppressive medications are prednisone 
10 mg/day and cyclosporine A 250 mgjday (3.2 mgjkg/day). 
His past medical history is also significant for chronic hepatitis 
B infection with probable cirrhosis, hypertension, goutyarthri-
tis, and lower extremity venous thrombosis. There is no history 
of previous derma to logic problems or intravenous drug abuse. 
He has never traveled outside the continental United States. 
On July I, 1988 he developed pain in the right elbow which 
became progressively worse, especially at night, and he pre-
sented for evaluation in Transplant Clinic on July 5. There 
was no history of trauma to the arm or any other difficulty. At 
that time he was afebrile. Examination of the right arm revealed 
moderate swelling with tenderness to palpation and motion in 
the area of the right elbow. The musculature of the arm ap-
peared normal. His laboratory parameters were within normal 
limits. Because of a past history of gouty arthritis an empiric 
trial of colchicine and indomethacin was begun. After initial 
improvement the pain began to worsen dramatically and be-
came constant, with subjective fever and increased swelling in 
the upper arm. 
The patient was hospitalized for further evaluation on July 
22, 1988. At that time physical examination showed the tem-
perature to be 38.2·C, blood pressure 118/78, respirations of 14 
per minute, and pulse of 88. The patient was in moderate 
distress from right arm pain. The right upper arm was edema-
tous and the inner aspect of the upper arm was exquisitely 
